BridgeBio Announces FDA Acceptance of NDA for Encaleret for ADH1
Go back to BridgeBio Announces FDA Acceptance of NDA for Encaleret for ADH1| (NASDAQ: BBIO) | Delayed: 72.83 +0.39 (0.54%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $72.44 | 52 Week High | $ | |||
| Open | $72.55 | 52 Week Low | $ | |||
| Day High | $73.67 | P/E | N/A | |||
| Day Low | $72.21 | EPS | $ | |||
| Volume | 634,859 | |||||
